Rick J. Barnett joined Satellite Healthcare in September 2014, bringing more than 30 years of experience at some of California's leading hospitals and ambulatory care centers. Most recently, Mr. Barnett was Sr. Vice President of VHA Inc., responsible for the enterprise on a national level, while simultaneously fulfilling his responsibilities as Executive Officer of the West Coast Region. In his roles at VHA, Mr. Barnett directed a network of more than 100 hospitals and related entities across Arizona, California, Hawaii, Nevada, Oregon, and Washington. Prior to that, Mr. Barnett served as President and CEO of Mercy Medical Center Redding; President and CEO of Mercy Medical Center Mt. Shasta; and Sr. Vice President and COO of Queen of the Valley Hospital in Napa.
As President and CEO for Satellite Healthcare, Mr. Barnett is responsible for managing the organization's strategic plans, which include further establishing Satellite Healthcare as the nation's leading not-for-profit organization dedicated to the advancement of care for people with kidney disease.
Mr. Barnett is a member of the American College of Health Care Executives, the Medical Group Management Association, the American Management Association, and the Adaptive Business Leaders Organization. He has held seats on numerous boards ranging from The Hospital Council of Northern California to various non-profit, government, and university organizations. He holds a Master’s of Business Administration from California State University at Fullerton and a Bachelor's Degree in Business Administration from Pacific Union College.
C. Bradford Jeffries, Esq., is co-founder of Satellite Healthcare, Inc. Mr. Jeffries received his undergraduate and law degrees from Stanford University and Stanford Law School. He is a retired partner of the prominent Cooley law firm, where he developed a national reputation as an emerging company and venture capital lawyer. Brad co-founded Sigma Management, a highly respected venture capital group and Venture Investment Associates, (which began its business as a successful venture capital ”Fund of Funds”) by acquiring the venture capital portfolio of American Express Company. Brad was also founding Chairman of Asia Renal Care, a Singapore dialysis company Satellite and some private investors formed to provide dialysis services in Asia. Brad is a former president of the Kidney Foundation of Northern California and was named the Northern California Kidney Foundation’s “Man Of The Year” in 1994. Brad has served as a director of Satellite Healthcare for more than 35 years.
William J. Long Long is Chairman of the Board and brings 25 years of venture capital and investment banking experience in the San Francisco Bay Area to DISCERN Advisors, DISCERN Group's Investment Advisory arm. Bill joined DISCERN Advisors after his recent tenure at Mohr Davidow Ventures, where he worked with technology, life science and clean tech companies on equity and debt financing. From his deep experience with managing IPOs and M&A transactions, Bill assisted a number of Mohr Davidow companies. His venture capital experience also includes co-heading TriplePoint Capital's Private Equity Group where he invested with other leading venture capital and private equity firms and has a distinguished record of investment performance. Bill's investment banking experience includes serving as a senior banker at JPMorgan in San Francisco and at predecessor Hambrecht & Quist, where he worked with a number of internet, technology and life science clients on raising capital and providing advice on mergers and acquisitions. Earlier in his career, Bill worked as an investment banker at Alex, Brown & Sons and served as a commercial loan officer for Maryland National Bank. He is a graduate of the Loyola University, Baltimore, where he earned a B.A. in Business Administration.
Daniel R. Herlinger, LFACHE, is currently a senior consultant for Arthur S. Shorr & Associates, Inc., a management firm providing business and strategic planning services in the healthcare field. Prior to this, Mr. Herlinger served as President and CEO of CHW Central Coast, overseeing the operations of four hospitals including St. Francis Medical Center, Marian Medical Center, St. John's Regional Medical Center and St. John's Pleasant Valley Hospital in California. Before this time, he served as Vice President of Mercy Hospital and Medical Center in Chicago. Mr. Herlinger is a life fellow in the American College of Healthcare Executives and an active member of a number of industry organizations. He currently serves on the board of CenCal Health, Cognitive Fitness & Innovative Therapies, Santa Barbara Rental Housing Mediation Task Force and the California Cooperative Healthcare Reporting Initiative. He is a health policy advisor for AARP and a certified mediator. He received his B.S. from Loyola University of Chicago, and his MBA in healthcare administration from The George Washington University.
Glenn Matthew Chertow, MD, MPH is the Norman S. Coplon Satellite Healthcare Professor of Medicine and (by courtesy) of Health Research and Policy, and Chief, Division of Nephrology at Stanford University School of Medicine. Dr. Chertow completed his undergraduate education at University of Pennsylvania and medical education at Harvard. He completed residency in internal medicine and fellowship in nephrology at Brigham and Women’s Hospital before joining the Harvard faculty, where he remained until 1998. He then joined the faculty at University of California San Francisco, where he served as Director of Clinical Services in the Division of Nephrology and was promoted through to full Professor in the Departments of Medicine and Epidemiology and Biostatistics until joining the Stanford faculty in 2007.
Throughout his more than 20 years of experience in nephrology, Dr. Chertow has published more than 200 articles and received numerous honors and awards. In addition to an active clinical practice, administrative responsibilities, teaching and mentoring, Dr. Chertow has developed and maintained a robust clinical research program. He has served or is currently serving in leadership roles for multiple NIDDK-, NHLBI-, and VA-sponsored clinical trials, including HEMO, DAC, ATN, FHN, SPRINT, PRESERVE, ISCHEMIA, CURE-GN and TiME, and for several industry-sponsored clinical trials including TREAT, EVOLVE, BEACON, SYMPLICITY, REPRISE, CREDENCE, and DAPA-CKD. He has served in an advisory capacity to the Medicare Payment Advisory Committee and the National Quality Forum on issues related to the ESRD program, on National Institutes of Health study sections and in multiple roles with the American Society of Nephrology (ASN), including the Public Policy Board, Quality Metrics Taskforce, and as Journal of the American Society of Nephrology (JASN) Associate Editor. He is Co-Editor of Brenner and Rector’s The Kidney.
Dr. Chertow was honored by the American Kidney Fund in 2007 with the National Torchbearer Award and in 2011 with the Nephrologist of the Year Award, in recognition of his contributions to the care of persons with kidney disease. Dr. Chertow was elected to the American Society of Clinical Investigation in 2004, and in 2015, received the Belding H. Scribner Award from ASN and was elected to the Association of American Physicians and the National Academy of Medicine. In 2018, Dr. Chertow received the David M. Hume Memorial Award, the highest honor given by the National Kidney Foundation to a distinguished scientist-clinician in the field of kidney and urologic diseases.
John Panetta received his undergraduate degree and Master of Law and Taxation from Georgetown University. He has more than 20 years of experience in the exempt organization tax area. John has led the Western Area Exempt Organizations Tax Practice of an international professional services firm. He also served with the Exempt Organizations Branch of the IRS National Office. A frequent lecturer, John has served as an adjunct faculty member of the School of Taxation at Golden Gate University, and as a visiting lecturer at the Graduate School of Business at Stanford University. He is a member of the Maryland Bar Association, District of Columbia Bar Association, National Association of College and University Business Officers, and American Health Lawyers Association.
Tom Williams, Dr PH, MBA joined Stanford Health Care in January 2015 as Vice-President and General Manager of Accountable Care. He is responsible for the growth and operations of Stanford Health Care Advantage, a Medicare Advantage health plan and Stanford Health Care Alliance, an Accountable Care Organization (ACO) product offering for the self-insured employer market. He is also responsible for Affinity Medical Solutions, which manages claims payment, network and utilization management, regulatory compliance and the financial performance of Stanford Health Care product offerings and “at risk” managed care contracts.
Prior to joining Stanford Health Care, Mr. Williams successfully led the Integrated Healthcare Association (IHA), a California leadership group with balanced representation from major health plans, hospital systems, physician organizations and other healthcare stakeholders. In his role as CEO, Mr. Williams was responsible for management of a broad range of programs and initiatives, including its nationally recognized quality measurement and pay-for-performance program, value-based payment pilots, efforts to enhance the adoption of health information technology and a variety of initiatives to improve healthcare affordability. He also served as principal investigator or research associate in several IHA grant funded research studies.
Mr. Williams’ professional career includes extensive executive-level experience in medical group management, managed healthcare, and health insurance, including 15 years as a senior executive at Aetna. He served as President, West Region during his last six years at Aetna. He has led the development of many HMO and related start-ups, post-merger integration activities and served on numerous private company and non-profit boards involved in healthcare and the environment.
Mr. Williams received a bachelor of science in biology from the University of California at Santa Barbara, earned master’s degrees in business administration and public health from the University of Hawaii, and a doctoral degree in public health at the University of California at Berkeley.
Sarah Blanchard, Chief Financial Officer and Chief Operating Officer at Omada Health based in San Francisco. Ms. Blanchard is an innovation leader having most recently served as Chief Innovation Officer and Vice President of Healthcare Trend for Humana.
At Humana, Ms. Burr led the enterprise-wide innovation strategy and efforts to build new customer-centric platforms, products, and solutions to help customers engage with their health, and bend the trend on medical costs. She also founded Humana's Health Ventures group, charged with identifying, partnering and investing in the most-promising emerging companies in the healthcare space. Additionally, her diverse background includes roles at Gap, Inc., Credit Suisse First Boston, eBay and Citi.
Ms. Burr received a Bachelor of Arts in Economics from Smith College and a Masters of Business Administration from Stanford University Graduate School of Business. She served as an observer on the board of directors of two innovative, early-stage healthcare companies, Omada Health and Livongo.